Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 25.75
-0.05 (-0.19%)
Apr 20, 2026, 10:00 AM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 5.75 billion as of April 17, 2026. Its market cap has decreased by -27.22% in one year.
Market Cap
5.75B
Enterprise Value
5.32B
Revenue
1.40B
Ranking
n/a
PE Ratio
28.52
Stock Price
25.75
Market Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 5.75B, an increase of 39.80%. That is a compound annual growth rate of 2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 5.75B | -1.34% |
| Dec 31, 2025 | 5.83B | -27.36% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.07B |
| Standard Chemical & Pharmaceutical | 11.26B |
| Alar Pharmaceuticals | 11.22B |
| Formosa Laboratories | 6.34B |
| LIWANLI Innovation | 6.11B |
| SCI Pharmtech | 5.80B |
| Easywell Biomedicals | 5.42B |
| Orient EuroPharma | 4.11B |